trending Market Intelligence /marketintelligence/en/news-insights/trending/_ijgNv-ixH2JQT-fmRJVvA2 content esgSubNav
In This List

CanniMed receives Health Canada's approval to produce medical cannabis capsules

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


CanniMed receives Health Canada's approval to produce medical cannabis capsules

Health Canada granted CanniMed Therapeutics Inc. license to produce medical cannabis capsules.

The company has initiated production of its CanniMed capsules following receipt of the production license.